A Randomized Phase 2 Placebo-Controlled Study of LY2495655 in Patients With Advanced or Metastatic Pancreatic Cancer Receiving Chemotherapy
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Landogrozumab (Primary) ; Antineoplastics; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Mar 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jul 2015 Planned End Date changed from 1 Jun 2015 to 1 Sep 2015, as reported by ClinicalTrials.gov.
- 09 Apr 2015 Planned End Date changed from 1 Feb 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov